Export

Ledipasvir + sofosbuvir
Essential medicine status
General description

INN
Ledipasvir + sofosbuvir
Medicine type
Chemical agent
EML status history
First added in 2015 (TRS 994) for Chronic hepatitis C
Therapeutic equivalent for
Recommendations
Section
Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations
  • Oral > Solid: 90 mg + 400 mg tablet